Chinese Acute Ischemic Stroke Treatment Outcome Registry
试验速览
- 阶段
- 不适用
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- death or severe disability
研究概览
简要总结
This is a multi-center registry study. The investigators will include 10,000 patients with confirmed acute ischemic stroke in China. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.
详细描述
Stroke is a common disease in China. Compared to western countries, there are many treatment regimens used in clinical practice in China. But their treatment effects are not well validated. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age ≥18 yesrs
- •confirmed diagnosis of an ischemic stroke
- •admission within 1 week after onset of stroke or within treatment time window for patients of thrombolysis treatment
- •signed informed consent
排除标准
- •with intracerebral hemorrhage
- •with severe morbid (estimated survival duration less than 3 months)
- •could not provide follow-up information
结局指标
主要结局
death or severe disability
时间窗: 90 days
次要结局
未报告次要终点
研究者
Yining Huang
Professor
Peking University First Hospital
